JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 3 November 2003. doi:10.1083/jcb.200307035
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 718K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamazaki, S.
Right arrow Articles by Mekada, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamazaki, S.
Right arrow Articles by Mekada, E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/2003/11/469 $8.00
The Journal of Cell Biology, Volume 163, Number 3, 469-475


Report

Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities



Satoru Yamazaki1, Ryo Iwamoto1, Kazuko Saeki2, Masanori Asakura3, Seiji Takashima3, Ayano Yamazaki1, Rina Kimura1, Hiroto Mizushima1, Hiroki Moribe1, Shigeki Higashiyama6, Masayuki Endoh4, Yasufumi Kaneda4, Satoshi Takagi5, Satoshi Itami5, Naoki Takeda7, Gen Yamada7 and Eisuke Mekada1

1 Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan
2 Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan
3 Department of Internal Medicine and Therapeutics, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan
4 Division of Gene Therapy Science, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan
5 Department of Dermatology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan
6 Department of Medical Biochemistry, Ehime University School of Medicine, Ehime 791-0295, Japan
7 Center for Animal Resource and Development and Graduate School of Molecular and Genomic Pharmacy, Kumamoto University, Kumamoto 860-0811, Japan

Address correspondence to Eisuke Mekada, Department of Cell Biology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan. Tel.: 81-6-6879-8286. Fax: 81-6-6879-8289. email: emekada{at}biken.osaka-u.ac.jp

Heparin-binding EGF-like growth factor (HB-EGF) is first synthesized as a membrane-anchored form (proHB-EGF), and its soluble form (sHB-EGF) is released by ectodomain shedding from proHB-EGF. To examine the significance of proHB-EGF processing in vivo, we generated mutant mice by targeted gene replacement, expressing either an uncleavable form (HBuc) or a transmembrane domain–truncated form (HB{Delta}tm) of the molecule. HBuc/uc mice developed severe heart failure and enlarged heart valves, phenotypes similar to those in proHB-EGF null mice. On the other hand, mice carrying HB{Delta}tm exhibited severe hyperplasia in both skin and heart. These results indicate that ectodomain shedding of proHB-EGF is essential for HB-EGF function in vivo, and that this process requires strict control.

Key Words: ectodomain shedding; ErbB; cardiomyopathy; valvulogenesis; epidermal hyperplasia


S. Yamazaki and R. Iwamoto contributed equally to this work.

The online version of this article includes supplemental material.

Abbreviations used in this paper: EGFR, EGF receptor; HB-EGF, heparin-binding EGF-like growth factor; proHB-EGF, membrane-anchored form of HB-EGF; sHB-EGF, soluble form of HB-EGF; TPA, O-tetradecanoylphorbol-13-acetate; tRA, all-trans retinoic acid.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents